Illumigen Biosciences - Ownership and Business Overview

Life ScienceCompany

Illumigen Biosciences Ownership

Who owns Illumigen Biosciences?

Illumigen Biosciences is owned by Cubist Pharmaceuticals. It was acquired on December 26, 2007.

Illumigen Biosciences Business Overview

Where is Illumigen Biosciences headquartered?

Illumigen Biosciences is headquartered in Seattle, Washington.

What sector is Illumigen Biosciences in?

Illumigen Biosciences is a life science company.

When was Illumigen Biosciences founded?

Illumigen Biosciences was founded in 2000.

Life Science M&A Summary in 2007

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.

Join Mergr to view all 131 acquisitions of life science companies in 2007, including 29 acquisitions by private equity firms, and 102 by strategics.

Illumigen Biosciences, Inc.

201 Elliott Avenue West, Suite 500,
Seattle, Washington 98119
United States,
(206) 378-0400

Illumigen Biosciences, Inc. discovers beneficial human genetic mutations that might provide a roadmap for novel therapeutic drug mechanisms.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.